Australia markets open in 9 hours 40 minutes

Luyan Pharma Co.,Ltd. (002788.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
7.90-0.08 (-1.00%)
At close: 03:04PM CST
Show:
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
606,303
594,190
415,434
596,915
-
Total cash
606,303
594,190
415,434
596,915
-
Net receivables
5,637,074
5,837,079
5,062,496
3,920,271
-
Inventory
2,574,076
2,548,589
2,274,989
2,028,122
-
Other current assets
55,659
39,877
59,433
46,987
-
Total current assets
9,318,574
9,748,241
8,322,289
7,197,851
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,995,853
1,719,806
1,284,974
1,180,939
-
Accumulated depreciation
-342,919
-294,589
-248,318
-200,164
-
Net property, plant and equipment
1,652,934
1,425,217
1,036,656
980,775
-
Goodwill
288,651
289,451
289,451
283,883
-
Intangible assets
355,164
176,934
167,810
113,234
-
Other long-term assets
10,683
1,395
64,062
45,222
-
Total non-current assets
2,475,021
2,035,555
1,670,406
1,497,761
-
Total assets
11,793,594
11,783,796
9,992,695
8,695,613
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
3,990,156
4,455,270
4,130,445
3,361,986
-
Accounts payable
3,444,468
3,258,174
2,410,500
2,006,354
-
Other current liabilities
2,891
3,916
1,907
2,492
-
Total current liabilities
8,026,158
8,301,010
7,015,230
5,963,284
-
Non-current liabilities
Long-term debt
578,629
471,764
223,485
110,990
-
Deferred tax liabilities
6,805
7,073
7,342
7,634
-
Deferred revenues
39,756
41,198
41,852
11,196
-
Other long-term liabilities
-
-
-
-
116,700
Total non-current liabilities
790,496
692,137
417,336
284,985
-
Total liabilities
8,816,654
8,993,147
7,432,566
6,248,269
-
Stockholders' equity
Common stock
388,517
388,517
388,517
388,517
-
Retained earnings
1,723,568
1,491,266
1,291,506
1,112,859
-
Total stockholders' equity
2,946,258
2,720,813
2,491,664
2,381,385
-
Total liabilities and stockholders' equity
11,793,594
11,783,796
9,992,695
8,695,613
-